Quick Answer
MoonLake Immunotherapeutics reported Long Term Debt of $74.10 million for the year ending 2025.
- This data is from MoonLake Immunotherapeutics's annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2025: $73.02 million | Q2 2025: $73.38 million | Q3 2025: $73.74 million.
- Historical annual values: Fiscal year 2025: $74.10 million | Fiscal year 2024: $0.00.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: